| McLeod RL, Mingo GG, Xu X, et al.
Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion. [JOURNAL ARTICLE]
Am J Rhinol Allergy 2009 Sep 18.
Abstract | Full Citation | Find Related Articles | | Manda B, Drinkard CR, Shatin D, et al.
The risk of esophageal obstruction associated with an anti-allergy medication (Claritin-D 24-Hour--original formulation). [Journal Article]
Pharmacoepidemiol Drug Saf 2004 Jan; 13(1):29-34.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Kaiser HB, Banov CH, Berkowitz RR, et al.
Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Am J Ther 1998 Jul; 5(4):245-51.
Abstract | Full Citation | Find Related Articles | | Ransom JH
Esophageal retention of loratadine plus pseudoephedrine extended-release tablets (Claritin-D 24 Hour). [Case Reports, Journal Article]
J Allergy Clin Immunol 1998 Feb; 101(2 Pt 1):287-8.
Full Citation | Publisher Full Text | Find Related Articles | | Kosoglou T, Radwanski E, Batra VK, et al.
Pharmacokinetics of loratadine and pseudoephedrine following single and multiple doses of once- versus twice-daily combination tablet formulations in healthy adult males. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Clin Ther 1997 Sep-Oct; 19(5):1002-12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Farinas E, Honig P
Upper gastrointestinal obstruction associated with Claritin-D 24 Hour Extended Release tablets. [Case Reports, Journal Article]
J Allergy Clin Immunol 1997 Sep; 100(3):427-8.
Full Citation | Publisher Full Text | Find Related Articles |  |
|
| |
Advertise on this site.
|
